ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Vice President, Program Leadership (Launch Products) at Mirum Pharmaceuticals - ApplyBlast

Vice President, Program Leadership (Launch Products)

Mirum Pharmaceuticals

19 days ago

4.0 on Glassdoor

Foster City, California, United States

Hybrid

Full Time

Executive

1 applicant

View Job Listing

Apply to 100+ jobs

About this role

The Vice President, Program Leadership (Launch Products) at Mirum Pharmaceuticals defines and drives the global strategy to maximize the long-term value of the company's late-stage products. This role leads a cross-functional team to ensure alignment around a single integrated product vision and strategy across the commercial-stage portfolio. The position operates as a 'Program CEO,' influencing executive leadership and bringing together cross-functional leaders around a shared vision.

Responsibilities

Define and execute integrated global lifecycle strategy for commercial products
Lead cross-functional teams to maximize product value and patient impact
Evaluate new indications and geographic expansion opportunities

Skills

About Mirum Pharmaceuticals

mirumpharma.com

Headquarters

Foster City, California, United States

Company Size

201-500 employees

Founded

2018

View Profile

Mirum Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing patient-inspired therapies for rare diseases where unmet medical need is greatest. The company has three approved medicines and a broad pipeline of investigational therapies spanning multiple rare disease areas, including cholestatic liver diseases and conditions such as Fibrodysplasia Ossificans Progressiva. Mirum combines deep rare disease expertise with regulatory strategy and patient access considerations to deliver meaningful treatments to small, high-need patient populations worldwide.